Collaborations & Alliances
-
Breaking News | Collaborations & Alliances | Process Development | Validation
Evotec, CHDI Extend Huntington's R&D Alliance
Will leverage Evotec's high-throughput screening and proteomics platforms09.12.14
-
Breaking News | Collaborations & Alliances | Process Development
MabVax, MSK, Juno Enter Antibody Discovery Pact
Will use MabVax platform to develop anti-cancer therapeutics09.11.14
-
Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Process Development
Seattle Genetics, Genmab Expand ADC Alliance
Genmab to pay $11 million for exclusive rights to Seattle Genetics' ADC technology09.10.14
-
Breaking News | Collaborations & Alliances | Process Development
AbbVie, Calico Establish R&D Alliance
Calico to build a new R&D facility in the San Francisco Bay Area09.04.14
-
Breaking News | Collaborations & Alliances | GMPs/GCPs | Process Development
Advaxis, Merck to Evaluate Immunotherapy Combo Drug
Phase 1/2 trial to evaluate ADXS-PSA and pembrolizumab in prostate cancer08.25.14
-
Breaking News | Collaborations & Alliances | Process Development
BMS, Celgene Enter Onco-Clinical Collaboration
Will evaluate combination regimen of nivolumab and ABRAXANE08.20.14
-
Breaking News | Collaborations & Alliances | Process Development
Emergent BioSolutions, MorphoSys Enter Prostate Cancer Drug Pact
Will initiate a Phase I trial of ES414 within the next six months08.20.14
-
Breaking News | Collaborations & Alliances
Evotec, MMV Enter Long-Term Drug Discovery Pact
Evotec to provide compound management services to support malaria research08.19.14
-
Breaking News | Collaborations & Alliances | Process Development
-
Breaking News | Capsules | Collaborations & Alliances | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Process Development
Sanofi, MannKind Enter Global Afrezza Pact
MannKind to manufacture inhaled insulin product for global commercialization08.12.14
-
Breaking News | Collaborations & Alliances | Process Development
Daiichi, Charleston Labs to Develop Hydrocodone Products
Fixed-dose combination tablet seeks to address pain and opioid-related illness08.08.14
-
Breaking News | Collaborations & Alliances | Process Development
-
Breaking News | Collaborations & Alliances | Process Development
Merck Serono, Kadimastem Enter Drug Screening Pact
Aims to advance compounds for neurodegenerative diseases08.04.14
-
Breaking News | Collaborations & Alliances | Process Development
-
Breaking News | Collaborations & Alliances | Process Development
Horizon, Otsuka in Development and Commercialization Pact
To perform in-vitro cell line screening of OPDC candidates07.25.14
-
APIs | Breaking News | Capsules | Collaborations & Alliances | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Process Development
Onyx to Manufacture API for Cancer Research UK
Will support a portfolio of drug substance campaigns07.22.14
-
Breaking News | Collaborations & Alliances
Anacor, Sandoz in KERYDIN Commercialization Pact
Companies enter long-term supply and profit-sharing arrangement07.21.14
-
Breaking News | Collaborations & Alliances | Process Development
-
Breaking News | Collaborations & Alliances | Process Development
-
Breaking News | Collaborations & Alliances | Process Development
HD Biosciences Enters Anti-cancer R&D Alliance
Aims to develop and commercialize drugs targeting international and Chinese markets07.15.14
